CSF3 and Schnyder corneal dystrophy: In SCD patients, HSC mobilization is challenging since several SCD-related factors impair HSC mobilization and collection, including the presence of damaged bone marrow, cytotoxic effects exerted by prior therapy with hydroxyurea, and, mostly, the inability to use G-CSF, which can trigger severe vaso-occlusive events [17].